Synexus and Radiant Research Announce Merger
Synexus and Radiant Research are merging their operations to form a single global site network of 185 sites with 1,500 employees.
Synexus and Radiant Research are merging their operations to form a single global site network of 185 sites with 1,500 employees. The enlarged entity will retain the Synexus name.
“We are delighted to be working together with the Radiant team,” said Christophe Berthoux, who has been chief executive officer for Synexus since 2010 and will lead the new company. “Best practices from Synexus, Radiant and our earlier acquisition of Research Across America will be incorporated across our global network of sites.”
Mike Clay will lead the U.S. operations of the combined business, reporting directly to Berthoux.
The new business will span 11 countries, offering access to more than 100 million patients in clinical development markets, and it will provide data-driven site selection and activation, combined with proven patient engagement and retention expertise across the U.S., Europe and Africa, according to Synexus.
Philip Ward is the European Editor for Applied Clinical Trials
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
